🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

IBM stock get bullish eyes from RBC, optimistic on AI and cloud

EditorEmilio Ghigini
Published 07/19/2024, 07:07 AM
© Reuters
IBM
-

On Friday, RBC Capital maintained its Outperform rating and $200.00 price target on IBM (NYSE:IBM) stock, traded on the New York Stock Exchange (NYSE:IBM). The firm's optimism is rooted in IBM's focus on software, specifically the areas of artificial intelligence (AI) and hybrid cloud, which are seen as key strategic themes.

In anticipation of the company's second-quarter results, RBC Capital highlighted the potential benefits of the ongoing infrastructure refresh cycle and positive outcomes from consulting peers.

The firm expects IBM to deliver solid performance for the quarter. Attention will be particularly given to the growth of Red Hat (RHT), the improvement of free cash flow (FCF) seasonality, and the market's sentiment towards IBM's AI initiatives, dubbed GenAI.

RBC Capital's stance remains unchanged, as the firm reiterates confidence in IBM's strategic direction and market position. The focus on AI and hybrid cloud is expected to continue driving the conversation around IBM's future prospects and financial health.

The firm's statement emphasized the qualitative aspects of GenAI sentiment alongside quantitative measures, suggesting a balance between tangible results and market perception. As IBM prepares to report its quarterly results, RBC Capital's maintained price target reflects a steady view of the company's value and potential for growth.

In other recent news, IBM secured a $26 million cybersecurity contract from the U.S. Agency for International Development (USAID). The five-year contract aims to enhance cybersecurity response for host governments in Europe and Eurasia. In other developments, analysts have been active in assessing IBM's prospects.

Bernstein SocGen Group and Evercore ISI have maintained Market Perform and Outperform ratings respectively, while Goldman Sachs initiated coverage with a Buy rating. BofA Securities also maintained a Buy rating, noting IBM's potential in General AI.

Analysts project IBM's revenue and EPS to grow steadily, with revenue projected to increase from $60,532 million in 2024 to $65,517 million in 2025, and EPS from $9.13 in 2024 to $10.34 in 2025. These projections are based on expectations from firms such as Evercore ISI, Bernstein SocGen Group, and Goldman Sachs.

In addition, IBM has made strategic moves such as the sale of its Qradar SaaS assets to Palo Alto Networks (NASDAQ:PANW), which is anticipated to result in a one-time increase in EPS and FCF. IBM's strategic focus on AI and hybrid cloud services, along with the potential for Red Hat to reaccelerate its performance, are seen as key drivers for the company's future growth.

InvestingPro Insights

As IBM gears up to report its quarterly results, real-time data from InvestingPro provides a quantitative backdrop to RBC Capital's qualitative optimism. IBM's market capitalization stands at a robust $170.14 billion, underscoring its substantial presence in the industry. The company's P/E ratio, a measure of its current share price relative to its per-share earnings, is at 20.14 for the last twelve months as of Q1 2024, suggesting a valuation that investors are willing to pay for its earnings growth potential.

InvestingPro Tips highlight IBM's status as a prominent player in the IT Services industry, having raised its dividend for an impressive 54 consecutive years. This consistency in dividend payments could be a reassuring signal for investors looking for stability in their investments. Additionally, analysts predict that the company will be profitable this year, a forecast that aligns with the positive sentiment expressed by RBC Capital.

For those seeking to delve deeper into IBM's financials and market performance, InvestingPro offers additional insights and tips that could further inform investment decisions. Readers can use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, gaining access to an extended list of valuable metrics and analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.